What this trial studies
Sexual health is not merely about sexual dysfunction, but a complex, diverse, and multifaceted natural process encompassing a wide range of aspects of human life, extending from childhood to old age. Quality of sexual life refers to an individual's satisfaction with their sexual life. Due to increased life expectancy, women spend more than a third of their lives in the postmenopausal period. Contrary to expectations, sexuality becomes increasingly important for women in the postmenopausal period.
Conditions in scope
- Sexual and Reproductive Health
- Menopausal and Postmenopausal Women
Interventions
- Group receiving sexual counseling based on the EX PLISSIT model. (Other) — Appointments will be scheduled for the women in the intervention group to meet at a convenient time and in a suitable environment at the hospital. Sexual counseling within the intervention group will be planned and implemented according to the 4…
Who can join
Women only · Ages 43 Years to 55 Years · Accepts healthy volunteers.
Inclusion criteria
- Being sexually active
- Living with a spouse/partner
- Having at least a primary school diploma
- Being in the postmenopausal period
- Agreeing to participate in the study
- Having entered menopause naturally
- Scoring ≤26.55 on the FSFI scal
Exclusion criteria
- Being on Hormone Replacement Therapy (HRT) and not having discontinued HRT treatment at least six months prior to the study
- Having undergone surgical menopause
- Not having entered menopause at an early or late age (over 40 and under 55 years of age)
- Having a chronic systemic disease and/or a psychiatric health problem
- Having a disability that makes communication difficult, such as hearing or language problems
- Having received any sexual counseling before the study
Eligibility wording paraphrased from the public record. View the full criteria on ClinicalTrials.gov before contacting a site.
Where it’s happening
| City | State / Region | Facility | Site status |
|---|---|---|---|
| Konya | Konya | Selcuk University | Unknown |
Status & timeline
- Overall status: Enrolling by invitation
- Study type: Interventional
- Phase: N/A
- Start date: 2026-02-01
- Primary completion: 2026-05-01
- Last update posted: 2026-05-07
- First posted: 2026-04-30
Sponsor & contact
Lead sponsor: Karamanoğlu Mehmetbey University (Other)
For trial site contact information, use the official record at ClinicalTrials.gov. Contact details change frequently and the public record is the source of truth.
Outcome measures
Primary outcomes
- Measuring the impact of sexual counseling based on the EX PLISSIT model (two months)
After sexual counseling based on the EX PLISSIT model, the Female Sexual Function Index (FSFI) scale were administered to women in the experimental and control groups via face-to-face interviews. The administration time for each scale varied between 15 and 20 minutes. Changes in the Female Sexual Function Index (FSFI) scale were measured two months after sexual counseling based on the…
Related ClearedRx care
If you’re reading this trial because you have menopause symptoms now, you don’t have to wait for a trial to access evidence-based care. ClearedRx prescribes the same FDA-approved and compounded HRT products that have been studied in trials like this one for decades.
Important. Information from ClinicalTrials.gov as of May 8, 2026. Trial details (status, sites, contacts, eligibility, outcomes) change frequently — always check the official record at https://clinicaltrials.gov/study/NCT07559916 before contacting a site.
ClearedRx is not affiliated with this trial or its sponsor. We index public-domain ClinicalTrials.gov records to help patients find evidence-based context for menopause care decisions. ClearedRx itself is a telehealth menopause/HRT brand — we do not enroll patients in trials.